Evaxion has received FDA approval to move forward with a Phase 2b clinical study for EVX-01
Evaxion Biotech A/S, a clinical-stage biotech company, announced that the FDA had given the green light for their Phase 2b clinical trial of EVX-01. The Company submitted an IND and Fast Track applica ...
USA: PD 1 Utilization in Advanced and Metastatic Melanoma – 2022
[vc_row][vc_column][vc_custom_heading text="USA: PD 1 Utilization in Advanced and Metastatic Melanoma - 2022" font_container="tag:h2|text_align:center" use_theme_fonts="yes"][/vc_column][/vc_row][vc_r ...